Generate Biomedicines, Inc. GENB Proceeds From Issuance Of Convertible Preferred Stock
Proceeds From Issuance Of Convertible Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock.
The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Generate Biomedicines, Inc. 's proceeds from issuance of convertible preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Generate Biomedicines, Inc. 's proceeds from issuance of convertible preferred stock?
- Generate Biomedicines, Inc. (GENB) reported proceeds from issuance of convertible preferred stock of $0 in Q1 2026.